{
  "meta": {
    "timestamp": "2025-01-06T09:38:23.247376",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Coloplast A/S",
      "symbol": "CLPBY",
      "analysis": {
        "historical": {
          "risk_score": 60,
          "key_risks": [
            "Regulatory and legal challenges, including significant settlements for safety violations and alleged kickbacks",
            "Supply chain vulnerabilities, particularly due to reliance on global suppliers and past disruptions",
            "Pricing and reimbursement pressures in key markets",
            "Environmental concerns related to plastic-based medical products"
          ],
          "controversies": [
            "$59 million settlement in 2019 for drug or medical equipment safety violations",
            "$14.5 million settlement in 2022 under the False Claims Act for alleged kickbacks to medical suppliers"
          ],
          "environmental_issues": [
            "Environmental impact of plastic-based medical products despite sustainability initiatives"
          ],
          "social_issues": [
            "Criticism of marketing practices and ethical concerns"
          ],
          "governance_issues": [
            "Past legal issues and ongoing regulatory scrutiny despite a Comprehensive Compliance Program"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Legal and Compliance - Coloplast US",
              "snippet": "Coloplast has developed a Comprehensive Compliance Program that we believe meets the compliance goals set forth by the California Health and Safety Code Chapter 8, \u00a7\u00a7 119400-119402. To the best of our knowledge, we are in compliance with our Comprehensive Compliance Program in all material respects.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341259+00:00",
              "published_date": null,
              "source_hash": "62a13ba258eb2ade01492514a0299796"
            },
            {
              "url": "",
              "title": "coloplast-as | Violation Tracker - Good Jobs First",
              "snippet": "Links: For a summary of this company's regulatory penalties in more than 50 other countries, see its Violation Tracker Global summary page here. ... Coloplast A/S: drug or medical equipment safety violation: 2019: private lawsuit-federal $59,000,000: Coloplast: False Claims Act and related: 2022: USAO $14,547,347:",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341373+00:00",
              "published_date": null,
              "source_hash": "435c732f0d7742592844952965fa6ed4"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Third parties working on Coloplast's behalf - whether employed or engaged by Coloplast A/S or by any of Coloplast's subsidiaries and associated companies - are also expected to follow the principles set out in the Coloplast BEST, and to comply with all relevant laws, regulatory, and contractual requirements.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341390+00:00",
              "published_date": null,
              "source_hash": "6848c710aea416cadec3c8f92bc2a7df"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Third parties working on Coloplast's behalf - whether employed or engaged by Coloplast A/S or by any of Coloplast's subsidiaries and associated companies - are also expected to follow the principles set out in the Coloplast BEST, and to comply with all relevant laws, as well as both regulatory and contractual requirements.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341401+00:00",
              "published_date": null,
              "source_hash": "ccf6731e5bee6e2b6d830e4503286ad9"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Welcome to Coloplast's Due Diligence Process 3 . Why is Due Diligence important? 4 . What are the benefits of Due Diligence? 4 . Is my organisation responsible for our business partners? 6. What if we already have a Compliance Programme? 6. Will Coloplast update me on the outcome of the . Due Diligence Process? 7 . Who can I contact if I have ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341412+00:00",
              "published_date": null,
              "source_hash": "0bbb5853dcb281be038fdd9eb2d1a38f"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Failure to comply with the Coloplast BEST Code of Conduct, or our relevant policies, can potentially bring penalties, sanctions or reputational harm to Coloplast and its employees and may result in internal corrective action up to and including termination. We are all expected to: \u2022 read and comply with the Coloplast BEST Code of Conduct",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341422+00:00",
              "published_date": null,
              "source_hash": "b40135124459773660119c399a311ab1"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "in relation to the financial reporting process for Coloplast A/S (\"oloplast\" or the \" company\") has been prepared pursuant to section 107b of the Danish Financial State-ments Act and forms an integral part of the Manage-ment's report in oloplas t's Annual Report for the finan-cial year 2022/23.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341434+00:00",
              "published_date": null,
              "source_hash": "7fee95f478e3c2f72829339598795608"
            },
            {
              "url": "",
              "title": "Business Ethics and Compliance - Corporate - Coloplast",
              "snippet": "The hiring of healthcare professionals by Coloplast is always based solely on the healthcare professional's suitability for the job and her or his professional abilities and qualifications. When engaging a healthcare professional Coloplast ensures that the compensation is proportionate to the services delivered, consistent with fair market ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341444+00:00",
              "published_date": null,
              "source_hash": "b37b1c913a7d36f426bd5f35850e580e"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "This Corporate Governance Report, including the description on internal controls and risk management systems in relation to the financial reporting process, for Coloplast A/S has been prepared pursuant to s. 107(b) of the Danish Financial Statements Act and forms an integral part of the Management's report in Coloplast /S' 9/ nnual Report ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341455+00:00",
              "published_date": null,
              "source_hash": "f0ed067fc7caae6c850d0d67706d522b"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "ance with Article 46(1), 46(2)(b), 47(1) and (47)(2) of the Data Protection Regulation. 1. 1. Appropriate guarantees . Before applying binding corporate rules, the exporter transferring personal data from a Mem- ... shown that Coloplast's binding corporate rules comply with the requirements of Article 47 of the GDPR and WP256 Rev.01.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Coloplast A/S Coloplast A/S regulatory fines or penalties",
              "retrieved_at": "2025-01-06T16:37:51.341465+00:00",
              "published_date": null,
              "source_hash": "a468238b9bf100d771a7504f33216ce7"
            },
            {
              "url": "",
              "title": "Coloplast A/S (OTCMKTS:CLPBY) Trading Down 2.3% - Here's What Happened",
              "snippet": "The business's fifty day simple moving average is $12.76 and its 200 day simple moving average is $12.86. Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) last issued its earnings results on ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:38:00.872086+00:00",
              "published_date": "2024-12-13T00:00:00+00:00",
              "source_hash": "1cf3d3b11ee7cbdf3d94aee9da134b12"
            },
            {
              "url": "",
              "title": "Coloplast A/S - Decisions at the Annual General Meeting 2024",
              "snippet": "Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:38:00.872287+00:00",
              "published_date": "2024-12-05T16:11:00+00:00",
              "source_hash": "dd14aa8023265f2f7c8db4ebe6e05d19"
            },
            {
              "url": "",
              "title": " Coloplast A/S, Plaintiff, MEMORANDUM OPINION AND ORDER - Justia Law",
              "snippet": "A/S (\"Coloplast\") concerning payments allegedly owed to Caldera under the parties' 2007 Intellectual Property Assignment Agreement (\"IP Assignment\"). Pursuant to that agreement, Caldera sold and assigned to Coloplast certain intellectual property rights related to a male stress urinary incontinence sling Coloplast A/S v.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356763+00:00",
              "published_date": null,
              "source_hash": "aefe00c142bb34e926622fbf04268f85"
            },
            {
              "url": "",
              "title": " United States District Court for The Northern District of Texas Abilene ...",
              "snippet": "3 6. Defendant Coloplast A/S is a corporation organized and existing under the laws of the Kingdom of Denmark maintaining its principal place of business at Holtedam 1, Humleback",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356832+00:00",
              "published_date": null,
              "source_hash": "172fbf02dcab65af10a408b3de6d0c0a"
            },
            {
              "url": "",
              "title": "Office of Public Affairs | Coloplast Corp. and Liberator Medical Agree ...",
              "snippet": "The Justice Department announced today that Coloplast Corp., a manufacturer of ostomy and continence care products, and Liberator Medical Supply, Inc., a supplier of medical products, have agreed to pay $3.16 million and $500,000, respectively, to resolve allegations that Coloplast paid kickbacks to several medical suppliers, including Liberator, to induce them to conduct promotional campaigns ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356847+00:00",
              "published_date": null,
              "source_hash": "211e258aa954ee1e0c7316848166c400"
            },
            {
              "url": "",
              "title": "Coloplast Corp. and Liberator Medical Agree to Pay $3.6 Million to ...",
              "snippet": "BOSTON - The U.S. Attorney's Office announced today that Coloplast Corp., a manufacturer of ostomy and continence care products, and Liberator Medical Supply, Inc., a medical products supplier, have agreed to pay $3,160,000 and $500,000, respectively, to resolve allegations that Coloplast paid unlawful kickbacks to several medical suppliers, including Liberator, to induce them to conduct ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356859+00:00",
              "published_date": null,
              "source_hash": "e1f689fb9d2b71afb448d742b641de56"
            },
            {
              "url": "",
              "title": "United States of America et al v. Coloplast A/S et al",
              "snippet": "Marketing Solutions. Justia Connect; Pro Membership; Basic Membership; ... Coloplast A/S et al Filing 341 Judge Rya W. Zobel: ORDER entered. Motion for Summary Judgment 301 is denied. ... Its Motion to Strike 317 is denied as moot consistent with the court's rulings herein. (DiBlasi, Lily)",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356870+00:00",
              "published_date": null,
              "source_hash": "591c94f9f6bd4c5f0fa7e1d22e13adcd"
            },
            {
              "url": "",
              "title": "Coloplast - History, Acquisitions, and Legal Troubles - Drugwatch",
              "snippet": "Coloplast's reported revenue in 2021 was $2.8 billion. ... The Ethisphere Institute \u2014 a think tank dedicated to ethics practices in business \u2014 named it one of the \"World's Most Ethical Companies\" in 2012 and 2013, though some have questioned the independence of the institute. ... Rasmussen told the Star Tribune that Coloplast was ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356880+00:00",
              "published_date": null,
              "source_hash": "c58a5f8026fced55e994283a72037abe"
            },
            {
              "url": "",
              "title": "Coloplast Corp will pay millions to resolve unlawful kickback ...",
              "snippet": "Coloplast Corp, an ostomy and continence care product manufacturer, has agreed to pay $3,160,000 to settle allegations it paid illegal kickbacks to a number of medical suppliers. Liberator Medical Supply Inc., one of five companies named in the kickback scheme, has agreed to pay $500,000 for their p",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356896+00:00",
              "published_date": null,
              "source_hash": "cce631bab007aa9fb643d766f206e630"
            },
            {
              "url": "",
              "title": " MDL No. 2387 In Re: Coloplast Corp., Pelvic Support System Products ...",
              "snippet": "owned U.S. sales and marketing subsidiary of Coloplast A/S, a Denmark corporation. 4. Defendant Mentor Worldwide LLC (\"Mentor Worldwide\") is, a limited liability corporation, incorporated in Delaware with an address of 1209 Orange Street, Wilmington, DE 19801, with a principal place of business at 5425 Hollister Avenue, Santa Barbara, CA 93111.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356908+00:00",
              "published_date": null,
              "source_hash": "8aa8fb2aff212754c8c4c0117a9fdfe2"
            },
            {
              "url": "",
              "title": "Coloplast cuts guidance amid challenges in UK, US",
              "snippet": "Denmark's Coloplast A/S (COLO-B.KO) Tuesday cut its fiscal 2014/15 guidance amid problems with prescription processing in its U.K. business as well as weaker U.S. activity due to a legal ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356918+00:00",
              "published_date": null,
              "source_hash": "44168327a868ff6d29dd4ac9cb8f549b"
            },
            {
              "url": "",
              "title": "Coloplast A/S : settles with the U.S. Department of Justice",
              "snippet": "Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:37:57.356927+00:00",
              "published_date": null,
              "source_hash": "207afe7666448302abe94ddc9c2485b4"
            },
            {
              "url": "",
              "title": "Coloplast A/S - Notice of Annual General Meeting 2024",
              "snippet": "Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Coloplast A/S Coloplast A/S marketing practices controversy",
              "retrieved_at": "2025-01-06T16:38:00.872324+00:00",
              "published_date": "2024-11-12T00:00:00+00:00",
              "source_hash": "c66109ad58ae5a279b1c777284f469ab"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Coloplast is a purpose-driven company. consumption now comes We work to make life easier for people with intimate healthcare needs. Every second, 47 people around the world pick up and use a Coloplast product to manage an intimate healthcare condition. renewable el operations in Denmark By improving standards of care, raising",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357249+00:00",
              "published_date": null,
              "source_hash": "7a4a6bc2ded0879f7c31fc97df1bf41a"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "As a manufacturer of medical products made primarily of plastic, Coloplast embraces our responsibility to contribute to solving the problems with plastic waste. We incorporate environmental assessment into the design of our products and packaging with a focus on recyclability and renewable materials such as recycled or bio-based.",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357327+00:00",
              "published_date": null,
              "source_hash": "cb29d7e770926850cf1c36c2881079e6"
            },
            {
              "url": "",
              "title": "Sustainability reporting and resources - Coloplast",
              "snippet": "Welcome to Coloplast's Investor Relations site. Read about our most recent news and financial results, upcoming events, see user videos and much more. Read more. ... Product sustainability; Collaboration & partnerships; Reporting and policies; News & Press Career Products Contact Sustainability reporting The world around us is changing. ...",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357343+00:00",
              "published_date": null,
              "source_hash": "0dbca734342b769ad8456a31528cfa20"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "with suppliers. For Coloplast to decouple environmental impact from economic growth, we need to work with our suppliers. Both in terms of identifying new materials with lower environmental impact and by collaborating with our suppliers to ensure environmentally friendly and socially responsible operations. During the coming financial",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357354+00:00",
              "published_date": null,
              "source_hash": "bac4ed7ff5ab7099e883af6bd89762a7"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "without increasing environmental pressure. Coloplast is a global company operating in more than 55 countries. We manufacture our products and distribute them around the world, and we're committed to providing intimate healthcare solutions for even more people in the coming years. Minimizing our impact requires a commitment to global environmental",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357365+00:00",
              "published_date": null,
              "source_hash": "422d88c14664b8101afd9004e3819546"
            },
            {
              "url": "",
              "title": "Coloplast AS 2021-2022 Sustainability Report - SustainabilityReports.com",
              "snippet": "The report highlights Coloplast's commitment to sustainability, emphasizing their Strive25 strategy aimed at reducing emissions, improving products and packaging, and operating responsibly. It details their progress on reducing scope 1 and 2 emissions by 8%, achieving 71% recycling of production waste, and securing a 100% renewable energy ...",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357374+00:00",
              "published_date": null,
              "source_hash": "d863b1d290e7a137127e808eb0dc5f63"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "eligible for reimbursement from local healthcare authorities. Coloplast supplies products to hospitals and institutions, as well as wholesalers and pharmacies. In select markets, Coloplast is also a direct supplier to users. Coloplast employs around 12,000 people and operates globally with sales subsidiaries in more than 40 countries.",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357433+00:00",
              "published_date": null,
              "source_hash": "0c5012bab2ee1fb787eea0aee3893875"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "seize opportunities to strengthen our environmental impact. Our partnerships, memberships and commitments include: Learn more and read our full Annual Report 2022/23 at sustainability.coloplast. com. 10% reduction in scope 1 & 2 emissions since 2018/19 75% of production waste recycling, thereby reaching our 2025 goal 100 top-emitting suppliers",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357443+00:00",
              "published_date": null,
              "source_hash": "ca46fae2280c4ae646661096e726d8c9"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "to Coloplast's mission to deliver safe and reliable products and services. Being responsible is a core value and has become a key theme in our corporate strategy. We apply a precautionary principle to mitigate, avoid or reduce social or environmental risks. We have clear governance for Quality and Sustainability with organisational anchoring ...",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357452+00:00",
              "published_date": null,
              "source_hash": "b59a697cf401cf839734d1bc937a228b"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Coloplast's approach to sustainability Atos Medical is focused on increasing the number of patients served\u2026 While reducing the environmental impact of its products and activities Key focus area #1: 2X number of customers served by 2025 ~50,000 new total laryngectomy surgeries per year \u2026of which only ~1/3 of patients are treated with products",
              "domain": "",
              "source_type": "web",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:02.357461+00:00",
              "published_date": null,
              "source_hash": "c50d2cbc5df9ed2834f42e939915a03c"
            },
            {
              "url": "",
              "title": "Coloplast A/S (OTCMKTS:CLPBY) Trading Down 2.3% - Here's What Happened",
              "snippet": "Coloplast A/S's payout ratio is currently 27.27%. Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom ...",
              "domain": "",
              "source_type": "news",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:05.750263+00:00",
              "published_date": "2024-12-13T00:00:00+00:00",
              "source_hash": "f4f5adafd150d2618d4353a3dbe91008"
            },
            {
              "url": "",
              "title": "Coloplast A/S - Decisions at the Annual General Meeting 2024",
              "snippet": "Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister ... continue to do so through innovative products and services.",
              "domain": "",
              "source_type": "news",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:05.750404+00:00",
              "published_date": "2024-12-05T16:11:00+00:00",
              "source_hash": "431560b51bb86621cda5a6031fbfa695"
            },
            {
              "url": "",
              "title": "Coloplast A/S - Notice of Annual General Meeting 2024",
              "snippet": "Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister ... continue to do so through innovative products and services.",
              "domain": "",
              "source_type": "news",
              "category": "environmental_safety",
              "query_context": "Coloplast A/S Coloplast A/S product environmental impact",
              "retrieved_at": "2025-01-06T16:38:05.750440+00:00",
              "published_date": "2024-11-12T00:00:00+00:00",
              "source_hash": "6f10f96e5e2dfa0eabb1eb2ef10e14e5"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Coloplast A/S regulatory fines or penalties",
              "rationale": "Investigate potential legal or financial risks from regulatory non-compliance",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Coloplast A/S marketing practices controversy",
              "rationale": "Explore ethical concerns related to marketing strategies and patient interactions",
              "priority": 2
            },
            {
              "category": "environmental_safety",
              "query": "Coloplast A/S product environmental impact",
              "rationale": "Assess environmental concerns related to product lifecycle and disposal",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T09:38:23.247381",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}